Web
Analytics
The news is by your side.

Bristol

Students raise £1,500 to send University cleaner on family holiday

BRISTOL: An adored university cleaner was reduced to tears after students raised money to send him to Jamaica on holiday. Happy Herman Gordon is loved by everyone at Bristol University for his positive attitude and happy-go-lucky nature. They decided they wanted to reward him and over 230 students donated to a JustGiving page that raised £1,500 for the family trip. He was called ‘the epitome of happiness’ by students as the crowdfunding appeal was launched. The Jamaican cleaner in the med library is…

England have no chance in Ashes without Stokes, says Chappell

LONDON: Former Australia captain Ian Chappell believes England “haven’t got a hope in hell” of winning the Ashes if all-rounder Ben Stokes is sidelined following a street brawl outside a Bristol nightclub. Stokes, vice-captain of the test side, was named in England’s 16-man squad for the Ashes tour starting in November but was suspended on Thursday until further investigation into the incident. “They can’t win without him (Stokes) for a number of reasons,” Chappell told Sydney’s Daily Telegraph on Thursday.…

England drop Stokes after his assault arrest

LONDON: England all-rounder Ben Stokes has been arrested on suspicion of causing actual bodily harm in Bristol and dropped for Wednesday's fourth one-day international against West Indies. The 26-year-old Durham star was arrested early on Monday in the Clifton district of the city and released under investigation -- without charge -- the England and Wales Cricket Board (ECB) announced Tuesday. Both Stokes and England opening batsman Alex Hales, 28, who was with him on Sunday night, will miss the game at The Oval. A…

Roche lung cancer drug success adds to pressure on Bristol

COPENHAGEN: Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb's dominant position in the field. The trial involved second-line patients, who have already used chemotherapy, and it found the Roche drug worked even in people with low or no levels of a protein called PD-L1, which is often used to test suitability for immunotherapy. The study results were presented at the annual European…